153 related articles for article (PubMed ID: 2428936)
1. Specific inhibition of dopamine D-1-mediated cyclic AMP formation by dopamine D-2, muscarinic cholinergic, and opiate receptor stimulation in rat striatal slices.
Kelly E; Nahorski SR
J Neurochem; 1986 Nov; 47(5):1512-6. PubMed ID: 2428936
[TBL] [Abstract][Full Text] [Related]
2. Dopamine D-2 receptors inhibit D-1 stimulated cyclic AMP accumulation in striatum but not limbic forebrain.
Kelly E; Nahorski SR
Naunyn Schmiedebergs Arch Pharmacol; 1987 May; 335(5):508-12. PubMed ID: 2441268
[TBL] [Abstract][Full Text] [Related]
3. M-1 and M-2 muscarinic receptor-mediated inhibition of dopamine-sensitive adenylate cyclase in rat neostriatum: a permissive role for D-2 dopamine receptors.
Schoffelmeer AN; Hogenboom F; Mulder AH
J Pharmacol Exp Ther; 1988 May; 245(2):658-63. PubMed ID: 2452877
[TBL] [Abstract][Full Text] [Related]
4. Acute reserpine treatment induces down regulation of D-1 dopamine receptor associated adenylyl cyclase activity in rat striatum.
Thomas KL; Rose S; Jenner P; Marsden CD
Biochem Pharmacol; 1992 Jul; 44(1):83-91. PubMed ID: 1321631
[TBL] [Abstract][Full Text] [Related]
5. Dissociation of the striatal D-2 dopamine receptor from adenylyl cyclase following 6-hydroxydopamine-induced denervation.
Thomas KL; Rose S; Jenner P; Marsden CD
Biochem Pharmacol; 1992 Jul; 44(1):73-82. PubMed ID: 1321630
[TBL] [Abstract][Full Text] [Related]
6. Characterization of dopamine and beta-adrenergic receptors linked to cyclic AMP formation in intact cells of the clone D384 derived from a human astrocytoma.
Balmforth AJ; Yasunari K; Vaughan PF; Ball SG
J Neurochem; 1988 Nov; 51(5):1510-5. PubMed ID: 2459312
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of dopamine-stimulated cyclic AMP efflux from rat neostriatal slices by activation of mu- and delta-opioid receptors: a permissive role for D-2 dopamine receptors.
Schoffelmeer AN; Hansen HA; Stoof JC; Mulder AH
Eur J Pharmacol; 1985 Dec; 118(3):363-6. PubMed ID: 2417870
[TBL] [Abstract][Full Text] [Related]
8. M1 muscarinic receptors contribute to, whereas M4 receptors inhibit, dopamine D1 receptor-induced [3H]-cyclic AMP accumulation in rat striatal slices.
Sánchez-Lemus E; Arias-Montaño JA
Neurochem Res; 2006 Apr; 31(4):555-61. PubMed ID: 16758365
[TBL] [Abstract][Full Text] [Related]
9. Muscarinic cholinergic receptor-mediated control of cyclic AMP metabolism. Agonist-induced changes in nucleotide synthesis and degradation.
Meeker RB; Harden TK
Mol Pharmacol; 1983 Mar; 23(2):384-92. PubMed ID: 6300648
[TBL] [Abstract][Full Text] [Related]
10. Neurochemical and behavioural evidence that dopamine D-2 receptors in striatum couple to the Ni regulatory protein and inhibition of cyclic AMP accumulation.
Kelly E; Willcocks AL; Nahorski SR
Naunyn Schmiedebergs Arch Pharmacol; 1987 Jun; 335(6):618-23. PubMed ID: 2819742
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of dopamine-sensitive adenylate cyclase by opioids: possible involvement of physically associated mu- and delta-opioid receptors.
Schoffelmeer AN; Hogenboom F; Mulder AH
Naunyn Schmiedebergs Arch Pharmacol; 1987 Mar; 335(3):278-84. PubMed ID: 3035383
[TBL] [Abstract][Full Text] [Related]
12. The use of cyclic AMP efflux studies in attempts to determine the effects of morphine on cyclic AMP formation in striatal slices.
Headley PM; O'Shaughnessy CT
Neuropharmacology; 1986 Aug; 25(8):919-22. PubMed ID: 3022183
[TBL] [Abstract][Full Text] [Related]
13. Interactions between opiate- and dopamine-induced effects on adenylate cyclase in rat striatum.
O'Shaughnessy CT; Headley PM
Eur J Pharmacol; 1986 Jun; 125(1):79-83. PubMed ID: 3015643
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of dopamine agonist-induced phosphoinositide hydrolysis by concomitant stimulation of cyclic AMP formation in brain slices.
Undie AS; Friedman E
J Neurochem; 1994 Jul; 63(1):222-30. PubMed ID: 7911510
[TBL] [Abstract][Full Text] [Related]
15. Guanine nucleotide binding proteins and the regulation of cyclic AMP synthesis in NS20Y neuroblastoma cells: role of D1 dopamine and muscarinic receptors.
Lovenberg TW; Nichols DE; Nestler EJ; Roth RH; Mailman RB
Brain Res; 1991 Aug; 556(1):101-7. PubMed ID: 1682005
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological and biochemical characterization of dopamine receptors mediating stimulation of a high affinity GTPase in rat striatum.
Onali P; Olianas MC
Biochem Pharmacol; 1987 Sep; 36(17):2839-45. PubMed ID: 2820423
[TBL] [Abstract][Full Text] [Related]
17. SCH 23390 blocks D-1 and D-2 dopamine receptors in rat neostriatum in vitro.
Plantjé JF; Daus FJ; Hansen HA; Stoof JC
Naunyn Schmiedebergs Arch Pharmacol; 1984 Sep; 327(2):180-2. PubMed ID: 6208489
[TBL] [Abstract][Full Text] [Related]
18. Cannabinoid receptor-regulated cyclic AMP accumulation in the rat striatum.
Bidaut-Russell M; Howlett AC
J Neurochem; 1991 Nov; 57(5):1769-73. PubMed ID: 1681035
[TBL] [Abstract][Full Text] [Related]
19. Differential effects of chronic agonist administration on mu-opioid receptor- and muscarinic receptor-regulated adenylate cyclase in rat striatal neurons.
Van Vliet BJ; Dotman CH; Wardeh G; Mulder AH; Schoffelmeer AN
Life Sci; 1992; 51(10):PL89-94. PubMed ID: 1325016
[TBL] [Abstract][Full Text] [Related]
20. D2-dopamine receptor-mediated inhibition of cyclic AMP formation in striatal neurons in primary culture.
Weiss S; Sebben M; Garcia-Sainz JA; Bockaert J
Mol Pharmacol; 1985 Jun; 27(6):595-9. PubMed ID: 2987658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]